Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...

More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match ...

The U.S. is the biggest single market for most pharma and biotech firms. Among the 10 largest biopharmaceutical companies in the Stoxx 600 health index, five get a majority of their total sales from ...

While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...

Retail traders debated the timing and pricing of the buyout, with some expecting an all-cash offer and others speculating ...

Add Yahoo as a preferred source to see more of our stories on Google. Nine big pharma companies have reached agreements with the Trump administration to lower prices for certain drugs in the US under ...

Executive compensation continues to be one of the most polarizing topics in pharma. An industry that generates trillions of dollars in revenue also features millions paid to CEOs and other top ...

AstraZeneca plans a $15B China investment amid cardio-metabolic and oncology growth. Read the latest analysis on AZN stock ...

Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies and the pharma market as a whole. Like all ...